{"filing":{"accession_number":"0001628280-26-056454","cik":"0001041024","ticker":"RMTI","company_name":"ROCKWELL MEDICAL, INC.","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"rmti-20260813.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026056454/rmti-20260813.htm"},"events":[{"id":27423,"run_id":24994,"accession_number":"0001628280-26-056454","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a straightforward quarterly earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release discloses net sales of $17.8 million (11% increase YoY), gross profit of $3.2 million (30% increase YoY), net loss of $1.2 million (improved from $1.5 million loss in prior year), and cash position of $24.8 million. The filing includes full financial statements and forward guidance for 2026. This is a material disclosure affecting investor assessment of the company's financial performance and operational trajectory.","company_name":"ROCKWELL MEDICAL, INC.","ticker":"RMTI","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":28955,"accession_number":"0001628280-26-056454","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a straightforward quarterly earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release discloses net sales of $17.8 million (11% increase YoY), gross profit of $3.2 million (30% increase YoY), net loss of $1.2 million (improved from $1.5 million loss in prior year), and cash position of $24.8 million. The filing includes full financial statements and forward guidance for 2026. This is a material disclosure affecting investor assessment of the company's financial performance and operational trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T10:14:38.654041+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28955,"accession_number":"0001628280-26-056454","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a straightforward quarterly earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release discloses net sales of $17.8 million (11% increase YoY), gross profit of $3.2 million (30% increase YoY), net loss of $1.2 million (improved from $1.5 million loss in prior year), and cash position of $24.8 million. The filing includes full financial statements and forward guidance for 2026. This is a material disclosure affecting investor assessment of the company's financial performance and operational trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T10:14:38.654041+00:00","company_name":"ROCKWELL MEDICAL, INC.","ticker":"RMTI","filing_date":"2026-08-13"}]}